InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by POYHONEN JOHN, Président et Directeur Commercial. Director active across 1 companies, notably Heron Therapeutics, INC.. Cumulatively, 9 filings have been published. The latest transaction was filed on 29 October 2021 — J. Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
1,250 shares
Common Stock
SEC:0001209191-22-024521:0·
1,250 shares
Common Stock
SEC:0001209191-22-003361·
1,250 shares
Common Stock
SEC:0001209191-22-003361:0·
€6,544817 shares@ €8.00990.0027% mcap37.0% of flow
Common Stock
SEC:0001209191-21-071173·
€6,544817 shares@ €8.00990.0027% mcap18.5% of flow
Common Stock
SEC:0001209191-21-071173:0·
1,250 shares
Common Stock
SEC:0001209191-21-060550·
1,250 shares
Common Stock
SEC:0001209191-21-060550:0·
€11,128971 shares@ €11.45990.0045% mcap63.0% of flow
Common Stock
SEC:0001209191-21-046789·
€11,128971 shares@ €11.45990.0045% mcap31.5% of flow
Common Stock
SEC:0001209191-21-046789:0·
9 of 9 declarations
About POYHONEN JOHN
John Poyhonen is the President and Chief Commercial Officer of Heron Therapeutics, Inc. He leads the company's commercial and strategic initiatives. His experience in the pharmaceutical sector is essential for the development and marketing of Heron's products.
